PMON162 Osilodrostat Provides Sustained Clinical Benefits and Improves Health-Related Quality of Life in Patients with Cushing's Disease: Results from the Phase III LINC 4 Study

BACKGROUND: Cushing's disease (CD) is a serious disorder associated with increased cardiovascular morbidity and mortality, and reduced patient quality of life (QoL), because of hypercortisolism. We report long-term effects of osilodrostat, a potent 11β-hydroxylase inhibitor, on cardiovascular/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Feelders, Richard, Gadelha, Mônica, Bex, Marie, Witek, Przemyslaw, Belaya, Zhanna, Yu, Yerong, Turcu, Adina F, Heaney, Anthony P, Auchus, Richard J, Piacentini, Andrea, Pedroncelli, Alberto M, Snyder, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625231/
http://dx.doi.org/10.1210/jendso/bvac150.1135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625231/
http://dx.doi.org/10.1210/jendso/bvac150.1135

Ejemplares similares